// App-Quantinova.ai

: Interactions Between Brain Structures and Genetic Variants in Neurotransmitter Systems as Potential Biomarkers for Hallucinations and Delusions in Alzheimer’s Disease (P1.1-012)

Researchers

Presenter

  • Juweiriya Ahmed

Principal Investigators

  • Andrew D. Robertson

  • Sejal Patel

  • Jo Knight

  • Derek Beaton

  • Lena Palaniyappan

  • Stephen Pasternak

  • Mario Masellis

  • Elizabeth Finger

Medical Centers

  • University of Waterloo, Waterloo, ON, Canada

  • Sunnybrook Health Sciences Centre, Toronto, ON, Canada

  • Centre for Addiction and Mental Health, Toronto, ON, Canada

  • Rotman Research Institute, Baycrest Health Sciences Toronto ON Canada

  • Department of Psychiatry, Schulich School of Medicine & Dentistry, Robarts Research Institute London ON Canada

  • Cognitive Neurology and Alzheimer’s Disease Research Centre London ON Canada

  • Clinical Neurological Sciences, University of Western Ontario London ON Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Cross-Sectional

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A